COVID-19: A case series to support radiographer preliminary clinical evaluation.

COVID-19 is the disease cause by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The World Health Organisation (WHO) declared COVID-19 a global pandemic on 11 March 2020. Radiographers, patient facing, frontline health professionals, have a key role in the diagnosis and management of COVID-19. Diagnosis of SARS-CoV-2 is confirmed by reverse transcription polymerase chain reaction (RT-PCR) of nasopharyngeal swabs. However, sensitivity is variable reported to be 70%–90% on initial swab and 90% on second swab at 72 h.

The British Society of Thoracic Imaging (BSTI) have developed a clinical decision support tool to aid clinicians, radiographers and radiologists when managing patients where COVID-19 is within the differential diagnosis – the chest radiograph (CXR) forms the bedrock of this tool. CXRs are a key diagnostic test when investigating patients with respiratory symptoms and are advocated as the first imaging examination in patients with suspected COVID-19. Mobile CXRs are an important diagnostic test in the evaluation of critically unwell patients, and in particular will have a role in minimising the transmission risk of SARS-CoV-2 associated with patient transfer. Baseline CXRs have a reported sensitivity of 69% compared to baseline RT-PCR thus far, but analysis has been lacking due to puzzlingly limited use of CXR in the outbreak to date.

Preliminary clinical evaluation (PCE) by radiographers at time of image acquisition is an expected competency of practitioners in many regions including the United Kingdom and Australia. As radiographers are almost invariably the first practitioner to see the diagnostic image, it follows that radiographer PCE and triage for an immediate clinical report plays a vital role in identifying possible COVID-19 patients. There are increasing case reports of patients presenting to hospital without classical symptoms of COVID-19 (fever, cough), including abdominal symptoms, , and may be referred for non-COVID diagnostic workup without respiratory precautions in place. Rapid radiographer PCE and triage will facilitate prompt reporting of the investigation, aid patient diagnosis and management decisions in a timely way. This rapid triage also allows for the potential of all imaging to be performed during a single hospital attendance and, more crucially, immediate appropriate decontamination of imaging equipment.

It is crucial that radiographers, radiologists and referring clinicians are aware that a normal imaging investigation (CXR or CT) does not exclude COVID-19 in high risk patients. Thus, a ‘completion’ chest CT to identify COVID-19 when the lung bases are normal on a routine CT abdomen in a patient who has no COVID-19 respiratory symptoms is not advocated. Also, personal protective equipment (PPE) and infection control precautions should continue, based on clinical suspicion. When imaging is abnormal, findings are frequently non-specific and need to be incorporated with the relevant clinical symptoms and findings on blood tests (most notably elevated C-reactive protein (CRP) and lymphopenia <1100 μ/L).

This case report series presents a summary of key findings frequently associated with COVID-19 and will assist radiographer PCE. Chest imaging features associated with COVID-19 (ref BSTI reporting template) are presented in Table 1 .

Table 1

Chest imaging features associated with COVID-19.

COVID-19	Imaging Features
Classic/Probable (>70% confidence)	• Bilateral • Lower zone predominance • Ground-glass • Peripheral
Indeterminate (<70% confidence)	Does not fit into definite or probable or Non-COVID.
Normal	• Does not exclude COVID-19 entirely. If the patient has clinical symptoms of COVID-19 RT-PCR should be considered.
Non-COVID	• Lobar pneumonia • Pleural effusion

A 69-year-old female presented to the emergency department with a three-day history of fever (temperature 38.2 C) and shortness of breath (oxygen saturation 87%), normal white cell count (6400 μ/L) but lymphopenia (890 μ/L) and an elevated CRP (149, normal <5). Mobile chest radiograph (Fig. 1 ) demonstrates classical findings associated with COVID-19 of bilateral, predominantly peripheral lower zone ground glass and interstitial opacification. Nasopharyngeal swab RT-PCR was positive for SARS-CoV-2.

Figure 1

Index chest radiograph of a 69 year old female with bilateral, peripheral ground glass and interstitial opacification (Classic/Probable COVID-19).

A 93-year-old female presented to the emergency department with a 10-day history of shortness of breath (oxygen saturation 66%), elevated CRP (71), normal white cell count (9500 μ/L) and lymphopenia (930 μ/L). Index (Day 0, Fig. 2 a) chest radiograph appearances were indeterminate with bilateral mid and lower zone interstitial opacification. Rapid progression occurred across seven days, with bilateral ground glass opacification (Fig. 2b) and development of acute respiratory distress syndrome (Fig. 2c). Nasopharyngeal swab RT-PCR was positive for SARS-CoV-2.

Figure 2

a. Index chest radiograph (Day 0) with unilateral lower zone interstitial opacification (Indeterminate COVID-19). b. Repeat chest radiograph day 5 with bilateral ground glass opacification in the lower zones (Classic/Probable COVID-19). c. Repeat chest radiograph day 7 with diffuse bilateral ground glass opacification (Classic/Probable COVID).

A 72-year-old male presented to the emergency department with a three-day history of right flank pain without dysuria and microscopic haematuria, temperature 37.1 C, oxygen saturation 98%, mildly elevated CRP, normal white cell count (4600 μ/L) and lymphocytes (1200 μ/L). A low dose CT abdomen was performed to investigate possible renal calculi. CT was negative for renal calculi however demonstrated subtle ground glass opacification of the left lower lobe (Fig. 3 a). CT chest was performed with peripheral ground glass opacification in the right upper lobe (Fig. 3b). Nasopharyngeal swab was not sent but the patient was given a clinical diagnosis of COVID-19.

Figure 3

a. CT abdomen with left lower lobe ground glass opacification (Indeterminate COVID-19). b. CT chest with right upper lobe peripheral ground glass opacification (Indeterminate COVID-19). Clinico-radiological diagnosis of COVID-19, swab not sent.

Conflict of interest statement

Unrelated to the current submission, Dr Nick Woznitza is a clinical advisor to InHealth, Dr Arjun Nair reports, unrelated to the current submission, part funding from the , and a medical advisory role with Aidence BV, an artificial intelligence company.